Evaluation of uricosuric agents in chronic gout.

Annals of the rheumatic diseases ·Vol. 16 ·No. 4 ·1957-12-00 ·Pages 425-37

OGRYZLO MA, HARRISON J

Abstract

暂无摘要

Keywords

GOUT/therapy

MeSH Terms

Arthritis, Gouty Chronic Disease Gout/therapy Humans Uricosuric Agents

Chemicals

Uricosuric Agents

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

OGRYZLO M A

HARRISON J

References (23)

23 references, click to expand

Effect of phenylbutazone on uric acid excretion in patients with gout and rheumatoid arthritis.
Proc Soc Exp Biol Med. 1953 Jul;83(3):603-5 PMID: 13088923
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.
J Pharmacol Exp Ther. 1957 Mar;119(3):418-26 PMID: 13417097
URIC acid metabolism and gout.
Am J Med. 1950 Dec;9(6):799-817 PMID: 14789798
The uricosuric action of ethyl biscoumacetate.
Lancet. 1955 Jun 11;268(6876):1191-7 PMID: 14382543
Probenecid (benemid); its uses and side-effects in 2,502 patients.
AMA Arch Intern Med. 1955 Jan;95(1):83-92 PMID: 13217507
The clinical and metabolic effects of benemid in patients with gout.
Trans Assoc Am Physicians. 1951;64:372-7 PMID: 14884273
The effect of phenylbutazone on uric acid metabolism in two normal subjects.
J Clin Invest. 1955 Feb;34(2):256-62 PMID: 13233347
Further observation on the uricosuric effects of probenecid (benemid) in tophaceous gout.
Trans Assoc Am Physicians. 1954;67:250-60 PMID: 13216834
Management of gout.
N Engl J Med. 1957 Jan 31;256(5):214-9; concl PMID: 13400237
Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone.
Am J Med. 1954 Feb;16(2):181-90 PMID: 13124349
Some observations on 520 gouty patients.
J Chronic Dis. 1955 Dec;2(6):645-69 PMID: 13271515
Oral phenylbutazone in the treatment of acute gouty arthritis.
Am J Med. 1956 Aug;21(2):232-6 PMID: 13339829
Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione).
Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):884-7 PMID: 13204385
The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject.
J Clin Invest. 1951 Aug;30(8):889-95 PMID: 14861311
Phenylbutazone (butazolidin) in gout.
Am J Med. 1954 Feb;16(2):212-7 PMID: 13124352
Radiological evidence of the value of treatment in gout.
Br J Radiol. 1952 Oct;25(298):539-41 PMID: 12978270
The effect of salicylates and adrenocorticotropic hormone upon the miscible pool of uric acid in gout.
J Clin Invest. 1950 Aug;29(8):1104-11 PMID: 15436881
Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.
J Clin Invest. 1953 Nov;32(11):1121-32 PMID: 13108975
Therapeutic value of probenecid (benemid) in gout.
J Am Med Assoc. 1952 Jul 26;149(13):1188-94 PMID: 14938138
The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use.
N Engl J Med. 1955 Sep 8;253(10):404-10 PMID: 13253847
Gout--now amenable to control.
Ann Intern Med. 1955 Jan;42(1):1-10 PMID: 13229184
Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.
J Clin Invest. 1956 Apr;35(4):374-85 PMID: 13306779
Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
J Clin Invest. 1952 Jul;31(7):692-701 PMID: 14938444

Article Info

Journal

Annals of the rheumatic diseases

Abbr.

Ann Rheum Dis

ISSN

0003-4967

DOI

10.1136/ard.16.4.425

Published

1957-12-00

Pages

425-37

Language

English

Region

England

NLM ID

0372355

PMCID

PMC1006984

Subset

External Links

PubMed source DOI: 10.1136/ard.16.4.425 PMC Full Text View journal details

Analysis Services

Evaluation of uricosuric agents in chronic gout.

Contact

WeChat Official Account